Attana participates at the First Congress of Clinical Biochemists and Laboratory Specialists of Serbia conference, KKBLM, Belgrade, November 27-29, 2019

The KKBLM-conference is intended for professionals in clinical biochemistry and laboratory medicine with a focus on the development of new laboratory tools and technology for medical diagnostics. The conference will be attended by leading specialists within industry and academia.

Attana will participate in the discussions and scientific sessions together with HVD Life Sciences and present at an exhibition booth. The focus will be to present how Attana’s 3rd generation biosensor is used in laboratory medicine and clinical biochemistry, biomarker screening and how it can increase the efficiency in the drug discovery process.

Read more about the conference here

HVD Life Sciences is Attana´s partner in Eastern Europe and Asia. Read more about our collaboration here

For more information, please contact:

Teodor Aastrup, CEO Attana AB
e-mail: teodor.aastrup@attana.com 
tel: + 46 8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact  sales@attana.com. 

Tags: